Two Notre Dame faculty from the Department of Aerospace and Mechanical Engineering have been awarded Project Development Team (PDT) grants on behalf of the Indiana Clinical and Translational Sciences Institute.
In order to provide an improved user experience, the Genomics & Bioinformatics Core Facility (GBCF) at the University of Notre Dame has launched a new website, genomics.nd.edu.
The goal of the website is to make accessing information related to Notre Dame Genomics and Bioinformatics easier, faster, and friendlier for all users. Information on the services available…
Holly Weiss-Bilka, a second year postdoctoral assistant in the Department of Biological Sciences, has been selected to present at the Association for Clinical and Translational Science’s (ACTS) annual meeting.
The Indiana Clinical and Translational Sciences Institute (CTSI) is currently seeking applications for the Collaboration in Translational Research (CTR) Pilot Grant Program. The objective of the CTR pilot grant program is to foster and encourage collaboration across the Indiana CTSI partner institutions and to initiate or continue translational research projects that have very strong and immediate potential to develop into larger, externally funded research programs or generate novel intellectual property.
Notre Dame Research has launched a new website dedicated to providing information on the Indiana Clinical and Translational Sciences Institute (CTSI) at the University. The website, ctsi.nd.edu, is a hub of information for the CTSI at Notre Dame, including funding opportunities.
"This website provides a wealth of information on the Indiana CTSI at Notre Dame," explained Rich Taylor, Associate Vice President for Research and Deputy Director of the Indiana CTSI. "We are striving to ensure our faculty and researchers are aware of the great opportunities our membership in the Indiana CTSI provides and to highlight the collaborative research partnerships that exist across the State of Indiana." …
The Indiana Clinical and Translational Science Institute (CTSI) is seeking applicants for the Collaboration in Translational Research (CTR) Pilot Grant Program.
The objective of the Indiana CTSI CTR pilot grant program is to foster and encourage collaboration across the Indiana CTSI partner institutions (IU, Purdue, and Notre Dame) and to initiate or continue translational research projects that have very strong and immediate potential to develop into larger, externally funded research programs, or generate novel intellectual property (IP).…
Nitesh Chawla, Frank Freimann Collegiate Associate Professor in the Department of Computer Science and Engineering and director of the Interdisciplinary Center for Network Science and Applications (iCeNSA) at the University of Notre Dame, is the recipient of the 2014 Rodney F. Ganey, Ph.D., Faculty Community-Based Research Award, which is given annually by the Notre Dame Center for Social Concerns.
The Indiana Clinical and Translational Sciences Institute, which includes the University of Notre Dame as a member, has received a nearly $30 million grant from the National Institutes of Health (NIH) to continue its mission of accelerating research discoveries across Indiana and beyond.
In work published this week in Nature: Scientific Reports, a team of researchers from the University of Notre Dame’s Eck Institute for Global Health, led by Associate Professor Giles Duffield and Assistant Professor Zain Syed of the Department of Biological Sciences, revealed that the major malaria vector in Africa, the Anopheles gambiae mosquito, is able to smell major human host odorants better at night.
The study reports an integrative approach to examine the mosquito’s ability to smell across the 24-hour day and involved proteomic, sensory physiological, and behavioral techniques.
Biochemistry graduate student Kerry Bauer recently received an Indiana Clinical and Translational Sciences Institute (CTSI) Predoctorial Trainee Award. The award includes an annual stipend, partial tuition for coursework relevant to her research, and travel support to attend a national meeting for similar trainees from 40 other medical schools and research institutions around the country.
A new paper by Crislyn D’Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
The new paper discusses the potential of microvesicles to present a combination of disease- and tissue-specific markers that would constitute a unique and identifiable biosignature for individual cancers.
The University of Notre Dame will host the Indiana Clinical and Translational Sciences Institute (CTSI) informational retreat Nov. 23 (Tuesday) from 10 a.m. to 3 p.m. at the Eck Visitors Center. Presenters will discuss the acceleration of the rate of health care innovation in Indiana and beyond through collaborations among the member universities as well as public and private partnerships.
Speakers will include Robert Bernhard, Notre Dame’s vice president for research; Anantha Shekhar, director of the Indiana CTSI; and Scott Denne, associate director of the Indiana CTSI. Participants also will hear about advances in medical science from Indiana CTSI investigators, who will discuss their research. Additional activities include a lunchtime poster session and afternoon breakout sessions.
Three University of Notre Dame faculty members—Basar Bilgicer, Bradley S. Gibson, and Paul Helquist—have been awarded grants from the Indiana Clinical and Translational Sciences Institute (Indiana CTSI) as part of the Collaboration in Translational Research Pilot Program. Another faculty member, Joshua Shrout, received a Young Investigator Basic Science award, and two graduate students — Apryle O’Farrell and James Clancy — have been awarded predoctoral fellowships by the organization.
Each of the CTSI-CTR teams, led by Bilgicer, Gibson and Helquist, will receive $75,000 to conduct research and foster collaborations focusing on new medical treatments and services.
The University of Notre Dame has been accepted as a formal partner in the Indiana Clinical and Translational Sciences Institute (ICTSI), a medical research initiative designed to systematically transform medical discoveries into improved patient care and business opportunities.
The National Institutes of Health (NIH) awarded a five-year Clinical and Translational Science Award (CTSA) of $25 million to the Indiana University School of Medicine in mid-2008 to fund CTSI activities at IU and Purdue University. The NIH created the clinical and translational awards program in an effort to improve the process by which the laboratory discoveries of basic science are transformed into new medical treatments and products — a process called translational research.
The University of Notre Dame will host a three-day conference on interdisciplinary biomedical research March 1 to 3 (Sunday to Tuesday) at the University’s McKenna Hall.
The keynote public lecture will be given March 1 by Anantha Shekhar, director of the Indiana Clinical and Translational Sciences Institute (I-CTSI) and professor of pharmacology and neurobiology at the Indiana University School of Medicine. His lecture, “Clinical and Translational Research Cycle: Complex Biomedical Modeling Approach to Human Diseases,” will begin at 5 p.m. in the McKenna Hall Auditorium.